Reports and Briefs on Pharmaceuticals

Published within

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

Type Product title / description Pub Price
Report
Report

H. Lundbeck A/S: PharmaVitae Report

Analysis of Lundbeck's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
09 Sep 2011 $2800
Buy
Report
Report

Biosimilars: Japan Update

Datamonitor’s report Biosimilars: Japan Update provides analysis on the Japanese biosimilars market. It includes an overview of drivers and resistors to biosimilars uptake, market access strategies, key players, and future development trends.

Published By Datamonitor
13 Sep 2011 $1520
Buy
Report
Report

Alexion Pharmaceuticals: PharmaVitae Report

This report analyzes Alexion's corporate strategy, sales outlook and financial position through to 2016, supported by in-depth analysis of the company’s key products, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
14 Sep 2011 $2800
Buy
Report
Report

Biosimilars: China Update

Biosimilars: China Update provides analysis on the Chinese biogenerics market. It includes an overview of drivers and resistors to biogeneric uptake, market access strategies, key biogeneric players and future development trends.

Published By Datamonitor
22 Sep 2011 $1520
Buy
Report
Report

Emerging Technologies: New Antibody-Based Technologies

Introduction to an emerging class of therapies in the high-growth therapeutic monoclonal antibody sector. Assessment of the sector's key technologies, players and products over the period 2010-16.

Published By Datamonitor
29 Sep 2011 $2800
Buy
Report
Report

Human Genome Sciences, Inc.: PharmaVitae Report

This report analyzes HGS's corporate strategy, sales outlook and financial position through to 2016, supported by in-depth analysis of the company’s key products, driven by patient-based forecasts and key opinion leader interviews.

Published By Datamonitor
13 Oct 2011 $2800
Buy
Report
Report

Biosimilars: India Update

Biosimilars: India Update provides analysis on the Indian copy biologics market. It includes an overview of drivers and resistors to biologic uptake, market access strategies, key domestic biologic players and future development trends.

Published By Datamonitor
14 Oct 2011 $1520
Buy
Report
Report

Otsuka Pharmaceutical Co., Ltd: PharmaVitae Report

Analysis of Otsuka's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
19 Oct 2011 $2800
Buy
Report
Report

Actelion Ltd: PharmaVitae Report

Analysis of Actelion's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Oct 2011 $2800
Buy
Report
Report

Gilead Sciences Inc.: PharmaVitae Report

Analysis of Gilead's corporate strategy, marketed portfolio, pipeline potential and financial position in 2010 and to 2016

Published By Datamonitor
20 Oct 2011 $2800
Buy

« | ... | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | ... | » »|

No help is available.